Llwytho...
Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most common type of liver cancer and one of the leading causes of cancer-related death worldwide. Advanced HCC displays strong resistance to chemotherapy, and traditional chemotherapy drugs do not achieve satisfactory therapeutic efficacy. Sorafenib is an oral k...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Theranostics |
|---|---|
| Prif Awduron: | , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Ivyspring International Publisher
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8039945/ https://ncbi.nlm.nih.gov/pubmed/33859758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.54822 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|